PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE.

• L. Minarik,
• T. Stopka,
• Z. Zemanova,
• A. Jonasova

Affiliations

L. Minarik

1 Clinic of Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague

T. Stopka

1 Clinic of Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague

Z. Zemanova

3 Center of Oncocytogenomics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czechia

A. Jonasova

1 Clinic of Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague